Clinica
J&J suffers knock-back in drug-eluting stent wars
26 January 2012
Tina Tan
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- TCT 2011: Medtronic’s new-gen DES shows benefits for diabetics; Endeavor beats Boston’s Taxus at five years
- Abbott's next-generation Xience DES gets US FDA green light
- Advantage to Boston in long-running DES patent dispute with J&J
- Boston added to "risk list" over acquisition-related and executive pay concerns
Other Informa News
EVENTS
